An Update on Genetics in Substance Use Disorders
Start Date: November 20, 2014
End Date: November 20, 2014
Thursday, November 20 from 1:00 to 2:00 PM, EST
This webinar qualifies for 1 CE credit.
To register for this event, click here
Naissan Hussainzada, PhD, Director of PGT Clinical Strategy
Recent research is shedding light on individual genetic variations and how those variations may impact an individual’s response to medications and illicit substances and can alert a treatment provider to the propensity for SUD. Current and future genetic tests available to support SUD treatment will be presented, along with ways to incorporate these tests to the therapeutic plan.
- Identify the neural substrates that mediate development and reinforcement of addiction
- Discuss how genetic and non-genetic factors contribute to risk and development of substance use disorders
- Identify emerging genetic targets that may mediate some of the physiological processes underlying addiction
- Understand the clinical implications of actionable pharmacogenetic testing during medication-assisted treatment of substance use disorders
The SAMHSA-HRSA Center for Integrated Health Solutions (CIHS) does not endorse or attest to the quality of the content. Questions regarding content, recordings, and additional information should be directed to the host organization and/or presenter.
More Info Url: